Physician profile
Darren L Wardle
NPI 1760566426
$1,368.71
in general payments reported to CMS, 2019-2025
23 companies · $195 in 2025
The $195 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2020: $83.14 · 2021: $197 · 2022: $212 · 2023: $340 · 2024: $139 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $674.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $304.84 | 2019-2023 | Krystexxa |
| Paragon 28, INC. | $208.07 | 2021-2024 | Apex 3d, Portfolio, Jaws |
| Smith+Nephew, INC. | $122.53 | 2019-2025 | Pico 7 |
| Stryker Corporation | $122.45 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $66.95 | 2019-2022 | |
| Bioventus LLC | $61.85 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Avanos Medical | $57.35 | 2019-2025 | On-Q Pump and Accessories |
| Orthofix Medical, INC. | $50.24 | 2022 | |
| Summit Surgical Corp. | $48.59 | 2023 | |
| Heron Therapeutics, INC. | $38.54 | 2021-2022 | |
| Voom Medical Devices, INC. | $38.52 | 2025 | Revcon Instrument Kit, Sterile |
| Zyla Life Sciences, INC. | $32.32 | 2019-2020 | |
| Anika Therapeutics, INC. | $31.86 | 2023 | Tactoset |
| Pacira Pharmaceuticals Incorporated | $25.50 | 2025 | Exparel |
| Solventum Corporation | $24.00 | 2024 | Promogran Prisma, 3m Cavilon, Prevena |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fusion Orthopedics USA, LLC | $22.59 | 2025 | |
| Invictus Surgical Incorporated | $21.67 | 2025 | |
| Arthrosurface Incorporated | $18.03 | 2019 | |
| Abbvie INC. | $17.44 | 2021 | |
| Integra Lifesciences Corporation | $16.04 | 2024 | Tcc-Ez |
| Amgen INC. | $15.79 | 2024 | Krystexxa |
| Depuy Synthes Sales INC. | $12.10 | 2022 | |
| Kerecis Limited | $11.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darren Wardle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.